Cowen Prime Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Cowen Prime Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-25	Closed	-$3K	–	183
2020 Q4	$3K	Hold	25	–	–	﹤0.01%	166
2020 Q3	$2K	Buy	+25	New	+$2.88K	﹤0.01%	175
2020 Q2	–	Sell	-25	Closed	-$2K	–	229
2020 Q1	$2K	Hold	25	–	–	﹤0.01%	187
2019 Q4	$3K	Hold	25	–	–	﹤0.01%	170
2019 Q3	$3K	Hold	25	–	–	﹤0.01%	151
2019 Q2	$4K	Hold	25	–	–	﹤0.01%	156
2019 Q1	$4K	Sell	25 -45	-64%	-$6.7K	﹤0.01%	154
2018 Q4	$7K	Sell	70 -100	-59%	-$13.1K	﹤0.01%	160
2018 Q3	$29K	Sell	170 -840	-83%	-$121K	0.01%	158
2018 Q2	$141K	Buy	1,010 +885	+708%	+$126K	0.07%	88
2018 Q1	$14K	Buy	+125	New	+$15.7K	0.01%	173

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cowen Prime Advisors's GWPH Position: Q1 2021 in Review

Cowen Prime Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 25 shares — an estimated $3K sold.

Cowen Prime Advisors first reported a position in GWPH in Q1 2018 and held it in 11 quarters. The position peaked at $141K in Q2 2018. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Cowen Prime Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Cowen Prime Advisors sold 25 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $3K.
Cowen Prime Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2018 and held it in 11 quarters.
Cowen Prime Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $141K in Q2 2018.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Cowen Prime Advisors's 13F filing for Q1 2021, filed 27 Apr 2021.